New oral insulin delivered via nano-carriers could soon replace injections

North­Star Med­ical Tech­nolo­gies, a Wis­con­sin-based man­u­fac­tur­er of ra­dio­phar­ma­ceu­ti­cals and ra­dioiso­topes, has named a new CEO. The man­u­fac­tur­er named for­mer COO Frank Scholz as CEO, re­plac­ing

Lex­eo Ther­a­peu­tics will be­gin trad­ing on the Nas­daq on Fri­day morn­ing via a $100 mil­lion ini­tial pub­lic of­fer­ing. The car­diac and Alzheimer’s gene ther­a­py biotech

Nor­mal­ly when a com­pa­ny scores on a pri­ma­ry end­point in a Phase III tri­al, those re­sults are re­leased as soon as pos­si­ble to not on­ly